These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 33305313)

  • 21. Candidemia Cases Caused by Candida parapsilosis Complex Species: Epidemiology and Antifungal Susceptibility of Strains.
    Cetinkaya O; Ozyurt OK; Kuskucu MA; Ozhak B; Ongut G; Yazisiz H; Ogunc D
    Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of Fluconazole Resistance Mechanisms and Clonal Types of
    Kim TY; Huh HJ; Lee GY; Choi MJ; Yu HJ; Cho SY; Chang YS; Kim YJ; Shin JH; Lee NY
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0088922. PubMed ID: 36226945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution.
    Díaz-García J; Gómez A; Alcalá L; Reigadas E; Sánchez-Carrillo C; Pérez-Ayala A; Gómez-García de la Pedrosa E; González-Romo F; Merino-Amador P; Cuétara MS; García-Esteban C; Quiles-Melero I; Zurita ND; Muñoz-Algarra M; Sánchez-Romero I; Durán-Valle MT; Sánchez-García A; Alcoceba E; Muñoz P; Escribano P; Guinea J;
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0071022. PubMed ID: 35852369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital Clonal Outbreak of Fluconazole-Resistant Candida parapsilosis Harboring the Y132F ERG11p Substitution in a French Intensive Care Unit.
    Presente S; Bonnal C; Normand AC; Gaudonnet Y; Fekkar A; Timsit JF; Kernéis S
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0113022. PubMed ID: 36853002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution.
    Mesquida A; Alcoceba E; Padilla E; Ramírez A; Merino P; González-Romo F; De Carolis E; Sanguinetti M; Mantecón-Vallejo MLÁ; Muñoz-Algarra M; Durán-Valle T; Pérez-Ayala A; Gómez-García-de-la-Pedrosa E; Del Carmen Martínez-Jiménez M; Sánchez-Castellano MÁ; Quiles-Melero I; Cuétara MS; Sánchez-García A; Muñoz P; Escribano P; Guinea J;
    Mycoses; 2024 Mar; 67(3):e13706. PubMed ID: 38438313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
    Rybak JM; Dickens CM; Parker JE; Caudle KE; Manigaba K; Whaley SG; Nishimoto AT; Luna-Tapia A; Roy S; Zhang Q; Barker KS; Palmer GE; Sutter TR; Homayouni R; Wiederhold NP; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
    Xiao M; Sun ZY; Kang M; Guo DW; Liao K; Chen SC; Kong F; Fan X; Cheng JW; Hou X; Zhou ML; Li Y; Yu SY; Huang JJ; Wang H; Xu YC;
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical azole cross-resistance in Candida parapsilosis is related to a novel MRR1 gain-of-function mutation.
    Branco J; Ryan AP; Pinto E Silva A; Butler G; Miranda IM; Rodrigues AG
    Clin Microbiol Infect; 2022 Dec; 28(12):1655.e5-1655.e8. PubMed ID: 36028086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
    Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
    J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance.
    Najafzadeh MJ; Shaban T; Zarrinfar H; Sedaghat A; Hosseinikargar N; Berenji F; Jalali M; Lackner M; James JE; Ilkit M; Lass-Flörl C
    Med Mycol; 2024 Mar; 62(4):. PubMed ID: 38521982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluconazole-resistant Candida parapsilosis complex candidemia and analysis of mutations in the ERG11 gene from Pakistan.
    Zeeshan M; Memon S; Malick A; Naqvi SF; Farooqi J; Ghanchi NK; Jabeen K
    Mycoses; 2024 Jan; 67(1):e13677. PubMed ID: 37990393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delineation of the Direct Contribution of Candida auris
    Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
    Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
    Morio F; Lombardi L; Binder U; Loge C; Robert E; Graessle D; Bodin M; Lass-Flörl C; Butler G; Le Pape P
    J Antimicrob Chemother; 2019 Aug; 74(8):2230-2238. PubMed ID: 31106355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
    Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
    BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
    Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in TAC1 and ERG11 are major drivers of triazole antifungal resistance in clinical isolates of Candida parapsilosis.
    Doorley LA; Barker KS; Zhang Q; Rybak JM; Rogers PD
    Clin Microbiol Infect; 2023 Dec; 29(12):1602.e1-1602.e7. PubMed ID: 37666448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First Canadian report of transmission of fluconazole-resistant
    McTaggart LR; Eshaghi A; Hota S; Poutanen SM; Johnstone J; De Luca DG; Bharat A; Patel SN; Kus JV
    J Clin Microbiol; 2024 Jan; 62(1):e0116123. PubMed ID: 38112529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.